MMM

MANGALAM DRUGS & O

No trades
See on Supercharts
Market capitalization
‪1.58 B‬INR
−10.75INR
‪12.70 M‬INR
‪3.71 B‬INR
‪13.43 M‬
Beta (1Y)
0.68

About MANGALAM DRUGS & O

CEO
Govardhan Murlidhar Dhoot
Headquarters
Mumbai
Employees (FY)
523
Founded
1972
ISIN
INE584F01014
FIGI
BBG000F8CMX7
Mangalam Drugs & Organics Ltd. engages in the manufacture of drugs, medicines and allied products. Its products include Acyclovir, Amodiaquine HCI, Bisoprolol Fumarate, Furosemide, Tenofovir Disoproxil Base, Lumefantrine, Bictegravir Sodium and Artemether. The company was founded in 1972 and is headquartered in Mumbai, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MANGALAM is 99.95 INR — it has increased by 0.81% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange MANGALAM DRUGS & O stocks are traded under the ticker MANGALAM.
MANGALAM DRUGS & O is going to release the next earnings report on May 30, 2024. Keep track of upcoming events with our Earnings Calendar.
MANGALAM stock is 2.18% volatile and has beta coefficient of 0.68. Check out the list of the most volatile stocks — is MANGALAM DRUGS & O there?
Yes, you can track MANGALAM DRUGS & O financials in yearly and quarterly reports right on TradingView.
MANGALAM stock has fallen by 3.62% compared to the previous week, the month change is a 4.11% rise, over the last year MANGALAM DRUGS & O has showed a 12.25% decrease.
MANGALAM net income for the last quarter is ‪4.98 M‬ INR, while the quarter before that showed ‪−35.64 M‬ INR of net income which accounts for 113.97% change. Track more MANGALAM DRUGS & O financial stats to get the full picture.
Today MANGALAM DRUGS & O has the market capitalization of ‪1.58 B‬, it has increased by 4.76% over the last week.
MANGALAM DRUGS & O dividend yield was 0% in 2022, and payout ratio reached 0%. The year before the numbers were 0% and 0% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, MANGALAM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MANGALAM DRUGS & O stock right from TradingView charts — choose your broker and connect to your account.
MANGALAM reached its all-time high on Dec 8, 2015 with the price of 442.40 INR, and its all-time low was 3.50 INR and was reached on Mar 21, 2014.
See other stocks reaching their highest and lowest prices.
As of Apr 21, 2024, the company has 523.00 employees. See our rating of the largest employees — is MANGALAM DRUGS & O on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MANGALAM DRUGS & O technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MANGALAM DRUGS & O stock shows the sell signal. See more of MANGALAM DRUGS & O technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MANGALAM DRUGS & O EBITDA is ‪59.22 M‬ INR, and current EBITDA margin is 7.03%. See more stats in MANGALAM DRUGS & O financial statements.